Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
Public ClinicalTrials.gov record NCT02104947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0g Idarucizumab (BI 655075) in Patients Treated Wtih Dabigatran Etexilate Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures.RE-VERSE AD (A Study of the RE-VERSal Effects of Idarucizumab on Active Dabigatran) Trial
Study identification
- NCT ID
- NCT02104947
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 503 participants
Conditions and interventions
Conditions
Interventions
- idarucizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2014
- Primary completion
- Jul 24, 2016
- Completion
- Oct 19, 2016
- Last update posted
- Jan 4, 2018
2014 – 2016
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baptist Health Center for Clinical Research | Little Rock | Arkansas | 72205 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010-2975 | — |
| University of Florida College of Medicine | Gainesville | Florida | 32610 | — |
| Baptist Medical Center | Jacksonville | Florida | 32207 | — |
| Mayo Clinic Cancer Center | Jacksonville | Florida | 32224 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| St. Joseph's Hospital | Tampa | Florida | 33607 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| OSF Saint Francis Medical Center | Peoria | Illinois | 61637 | — |
| IU Health Methodist Hospital | Indianapolis | Indiana | 46202 | — |
| Community Hospital | Munster | Indiana | 46321 | — |
| Our Lady of the Lake Regional Medical Center | Baton Rouge | Louisiana | 70808 | — |
| Newton-Wellesley Hospital | Newton | Massachusetts | 02462 | — |
| Genesys Regional Medical Center | Grand Blanc | Michigan | 48439 | — |
| Henry Ford Allegiance Health | Jackson | Michigan | 49201 | — |
| Mercy Hospital St. Louis | St Louis | Missouri | 63141 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| Miami Valley Hospital | Dayton | Ohio | 45409 | — |
| St. Elizabeth Youngstown Hospital | Youngstown | Ohio | 44501 | — |
| St. John Health System Inc | Tulsa | Oklahoma | 74104 | — |
| St. Mary Medical Center | Langhorne | Pennsylvania | 19047 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Health Research and Education Institute | Fort Worth | Texas | 76104 | — |
| Memorial Hermann Hospital - Texas Medical Center | Houston | Texas | 77030 | — |
| Sentara RMH Medical Center | Harrisonburg | Virginia | 22801 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298-0401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 146 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02104947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2018 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02104947 live on ClinicalTrials.gov.